Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cardiac hypertrophy and histone deacetylase–dependent transcriptional repression mediated by the atypical homeodomain protein Hop
Hyun Kook, … , Peter Gruber, Jonathan A. Epstein
Hyun Kook, … , Peter Gruber, Jonathan A. Epstein
Published September 15, 2003
Citation Information: J Clin Invest. 2003;112(6):863-871. https://doi.org/10.1172/JCI19137.
View: Text | PDF
Article Cardiology

Cardiac hypertrophy and histone deacetylase–dependent transcriptional repression mediated by the atypical homeodomain protein Hop

  • Text
  • PDF
Abstract

Activation of multiple pathways is associated with cardiac hypertrophy and heart failure. Repression of antihypertrophic pathways has rarely been demonstrated to cause cardiac hypertrophy in vivo. Hop is an unusual homeodomain protein that is expressed by embryonic and postnatal cardiac myocytes. Unlike other homeodomain proteins, Hop does not bind DNA. Rather, it modulates cardiac growth and proliferation by inhibiting the transcriptional activity of serum response factor (SRF) in cardiomyocytes. Here we show that Hop can inhibit SRF-dependent transcriptional activation by recruiting histone deacetylase (HDAC) activity and can form a complex that includes HDAC2. Transgenic mice that overexpress Hop develop severe cardiac hypertrophy, cardiac fibrosis, and premature death. A mutant form of Hop, which does not recruit HDAC activity, does not induce hypertrophy. Treatment of Hop transgenic mice with trichostatin A, an HDAC inhibitor, prevents hypertrophy. In addition, trichostatin A also attenuates hypertrophy induced by infusion of isoproterenol. Thus, chromatin remodeling and repression of otherwise active transcriptional processes can result in hypertrophy and heart failure, and this process can be blocked with chemical HDAC inhibitors.

Authors

Hyun Kook, John J. Lepore, Aaron D. Gitler, Min Min Lu, Wendy Wing-Man Yung, Joel Mackay, Rong Zhou, Victor Ferrari, Peter Gruber, Jonathan A. Epstein

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Hop recruits HDAC activity to repress transcription. (a) Cos cells were ...
Hop recruits HDAC activity to repress transcription. (a) Cos cells were transfected with a luciferase reporter plasmid including regulatory elements from the SM22α promoter with binding sites for SRF. Myocardin cotransfection induces dramatic activation assigned a value of 100% maximal activation (M). Cotransfection of myocardin and Hop (H) results in inhibition of myocardin-induced activation. The ability of Hop to inhibit myocardin-induced activation is attenuated in a dose-dependent fashion by TSA. (b) Hop inhibitory activity is also blocked by Scriptaid but not by Nullscript. (c) Immunoprecipitation of Hop from transfected Cos cells results in precipitation of HDAC activity. Cells were transfected with vector alone (pcDNA3) or myc-tagged control (pSecTag-PSA), Hop, or HopH2, followed by immunoprecipitation with anti-myc Ab. HDAC activity in the pellet was assayed and reported as arbitrary units (see Methods). Western blot analysis with anti-myc Ab of input material used for immunoprecipitation is shown below. (d) Chromatin immunoprecipitation reveals decrease in acetylated histones after Hop expression. The 10T1/2 cells were transfected as in a, followed by chromatin immunoprecipitation with Ab’s to acetylated histone H4 or H3 and detection of SM22α promoter fragments by PCR in precipitate. (e) Coimmunoprecipitation of HDAC2 and Hop. The 293T cells were transfected with control vector (pcDNA3), Hop, or HopH2, followed by immunoprecipitation and Western blot analysis for HDAC2. A Western blot using anti-HDAC2 Ab of the cell extracts used in each case is shown (Input).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts